Yeah, they seem to be moving it that way. I agree. RSI around 40 or bit below. I think your strategy is OK. I too am watching this as well and wondering where this will stick and support be found. It's not moving down with any big volume so I find that reassuring. Wait and see.
It's sort of obvious with the stock trading at prices before the drug got approved that the business model is not working. We will see what this Friday brings, but if we are still below 11,000, I don't know what else to say. I hope the longs (other than myself) will keep buying to provide support for my stock. Thanks guys.
It's not an inferior product. I have not spoken to any customers, but have heard from the various pharmacies that folks have lost weight and happy. One person stopped the drug due to elevated liver enzymes and not sure what was up with that: concurrent diseases, other meds they are taking, etc.
I just think its been a poor business model from the start.
Hey, what happened with MNKD? Any thoughts on that one? When will Sanofi start marketing Afrezza or have they already? Any strategies on HOW they plan to do this both with public and physicians? Interesting price right now.
Bummer for the buyer of those. I was looking to sell calls yesterday, but feared losing this stock. It's a volatile stock and I think underestimated which makes me hold my position. I was looking to add another 2000 shares to round out at 10,000 and sit it out. I think any company that can make money at these highs and innovate is worth holding. I consider GTAT a safe growth stock. One of the things people don't mind spending money is on phones. I personally am going to upgrade to this new iPhone after using Android for years. I have a Samsung 4 bought several months ago and not impressed. They are always doing upgrades to the phone and screwing things up and not crazy about the operating system any more. I think Apple will carry GTAT, but I feel they have enough uses for sapphire (commercial, other retail uses, military, etc) and along with their other products and manufacturing processes to carry their own. Lastly, I will watch the chart. If they bring this down again in the low 17's then I will consider picking up more if markets are not selling off.
Funny you talked about this stuff. I was thinking of some type of solar type installation on Tesla myself. Not as technical as you, but there are always possibilities.
Sentiment: Strong Buy
I say we retest resistance at old high in 2-3 weeks. If we break it and the good news is confirmed regarding sapphire, we might be seeing mid to high 20's September sometime. If those phones sell like hot cakes, we might be seeing 50-60 by end of the year.
Means the shorts will be paying 100 bucks a share. Hope they went to Costco and stocked up on the Kleenex to dry up their tears.
I agree with you that Europe is watching to see if any unusual adverse drug reactions are reported.
I'm impressed that his hit pieces are not having the effects that they used to. He's made his point numerous times that he thinks the whole thing is a hoax so why not shut up already unless there are ulterior motives.
Yes, ask how many patients' treated in Germany if they a hard count. Also, are they seeing more and more German neurologists using this as a treatment and do they (German neurologists) have a protocol as far as how long after radiation/resection/chemo.
When will revenues from Germany be recorded on the books? How much so far received from Germany if so? Are they able to disclose how many Euro's the total treatment will cost the Germans' per patient?
3 posts | Last Activity: 3 hours ago
Member since: Aug 19, 2013
Very interesting how this nut times his articles when some positive news comes for NWBO. It's not a coincidence any longer and I would hope SEC does investigate him and Cramer.
You have to watch the video on You Tube how Cramer talks about various manipulations done by the big guys to shake folks out of stocks and buy cheaper. Pretty sick, but this is how the world works unfortunately. The good thing is that with Internet these scams can be exposed and some folks are getting wiser.
Yesterday, the pharmacist I was working with said I have a Belviq script. No kidding. It was a refill. Copay in the $135ish range. Not cheap and this can be a hindrance to filling, as Spencer Osborne, has mentioned on SA.
On the bright side, I was surprised to see the daily count of Belviq to move from 32 to 13 in one day. That used to take about a week. Our supplier reordered drug and shows 100 again. It is nice to see weekly numbers approaching 11,000. Maybe this week?
On the negative side, I am awaiting Contrave. I would hope it wouldn't sell well, but will wait and see. I would consider adding at these prices to what I have remaining, but will watch this closely. As Osborne mentioned, maybe it will bring some legitimacy to the weight loss meds and lower copays overall.